https://www.selleckchem.com/products/snx-2112.html
Data on convalescent plasma therapy (CPT) in patients of hematological malignancies with severe Covid-19 is scarce. To study 14-day mortality in patients who received CPT. Retrospective multicentre observational study conducted in 4 centres treating haematological malignancies across Delhi-national capital region. Total 33 haematological malignancies patients with severe Covid-19 who received CPT were analysed. The median age of the study cohort was 62 years (18-80 years). Twenty one percent patients had 1 comorbidity, 18 % had 2 comor
Мне нравится
Комментарий
Перепост
